Esophageal Lichen Planus : A Descriptive Multicenter Report
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc..
GOALS: To better understand the characteristics, treatment approaches, and outcomes of patients with esophageal lichen planus (ELP).
BACKGROUND: ELP is a rare, often unrecognized and misdiagnosed disorder. Data on this unique patient population are currently limited to small, single-center series.
STUDY: A multicenter, retrospective descriptive study was conducted of adults diagnosed with ELP over a 5-year period, between January 1, 2015, and October 10, 2020, from 7 centers across the United States.
RESULTS: Seventy-eight patients (average age 65 y, 86% female, 90% Caucasian) were included. Over half had at least 1 extraesophageal manifestation. Esophageal strictures (54%) and abnormal mucosa (50%) were frequent endoscopic findings, with the proximal esophagus the most common site of stricture. Approximately 20% had normal endoscopic findings. Topical steroids (64%) and/or proton pump inhibitors (74%) dominated management; endoscopic response favored steroids (43% vs. 29% respectively). Almost half of the patients required switching treatment modalities during the study period. Adjunctive therapies varied significantly between centers.
CONCLUSIONS: Given its at times subtle clinical and endoscopic signs, a high index of suspicion and biopsy will improve ELP diagnosis, especially in those with extraesophageal manifestations. Effective therapies are lacking and vary significantly. Prospective investigations into optimal treatment regimens are necessary.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
|---|---|
| Enthalten in: |
Journal of clinical gastroenterology - 58(2024), 5 vom: 08. Apr., Seite 427-431 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Aby, Elizabeth S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 08.04.2024 Date Revised 08.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1097/MCG.0000000000001885 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359376797 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359376797 | ||
| 003 | DE-627 | ||
| 005 | 20240408232034.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/MCG.0000000000001885 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1369.xml |
| 035 | |a (DE-627)NLM359376797 | ||
| 035 | |a (NLM)37436831 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Aby, Elizabeth S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Esophageal Lichen Planus |b A Descriptive Multicenter Report |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2024 | ||
| 500 | |a Date Revised 08.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. | ||
| 520 | |a GOALS: To better understand the characteristics, treatment approaches, and outcomes of patients with esophageal lichen planus (ELP) | ||
| 520 | |a BACKGROUND: ELP is a rare, often unrecognized and misdiagnosed disorder. Data on this unique patient population are currently limited to small, single-center series | ||
| 520 | |a STUDY: A multicenter, retrospective descriptive study was conducted of adults diagnosed with ELP over a 5-year period, between January 1, 2015, and October 10, 2020, from 7 centers across the United States | ||
| 520 | |a RESULTS: Seventy-eight patients (average age 65 y, 86% female, 90% Caucasian) were included. Over half had at least 1 extraesophageal manifestation. Esophageal strictures (54%) and abnormal mucosa (50%) were frequent endoscopic findings, with the proximal esophagus the most common site of stricture. Approximately 20% had normal endoscopic findings. Topical steroids (64%) and/or proton pump inhibitors (74%) dominated management; endoscopic response favored steroids (43% vs. 29% respectively). Almost half of the patients required switching treatment modalities during the study period. Adjunctive therapies varied significantly between centers | ||
| 520 | |a CONCLUSIONS: Given its at times subtle clinical and endoscopic signs, a high index of suspicion and biopsy will improve ELP diagnosis, especially in those with extraesophageal manifestations. Effective therapies are lacking and vary significantly. Prospective investigations into optimal treatment regimens are necessary | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Steroids |2 NLM | |
| 700 | 1 | |a Eckmann, Jason D |e verfasserin |4 aut | |
| 700 | 1 | |a Abimansour, Jad |e verfasserin |4 aut | |
| 700 | 1 | |a Katzka, David A |e verfasserin |4 aut | |
| 700 | 1 | |a Beveridge, Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Triggs, Joseph R |e verfasserin |4 aut | |
| 700 | 1 | |a Dbouk, Mohamad |e verfasserin |4 aut | |
| 700 | 1 | |a Abdi, Tsion |e verfasserin |4 aut | |
| 700 | 1 | |a Turner, Kevin O |e verfasserin |4 aut | |
| 700 | 1 | |a Antunes, Catiele |e verfasserin |4 aut | |
| 700 | 1 | |a Zhuo, Justin |e verfasserin |4 aut | |
| 700 | 1 | |a Kamal, Afrin N |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Parth |e verfasserin |4 aut | |
| 700 | 1 | |a Gyawali, C Prakash |e verfasserin |4 aut | |
| 700 | 1 | |a Sloan, Joshua A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical gastroenterology |d 1980 |g 58(2024), 5 vom: 08. Apr., Seite 427-431 |w (DE-627)NLM000468495 |x 1539-2031 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2024 |g number:5 |g day:08 |g month:04 |g pages:427-431 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/MCG.0000000000001885 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 58 |j 2024 |e 5 |b 08 |c 04 |h 427-431 | ||